Clincosm LogoSign in Get a demo

KKMS39Penta: Keratoconus Detection Using MS39 and Pentacam

Sponsor
Johannes Kepler University of Linz (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05604443
Collaborator
(none)
200
Enrollment
1
Location
3
Anticipated Duration (Months)
67.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This retrospective study aims to investigate whether the MS39 and Pentacam are delivering comparable results in the diagnosis of keratoconus.

In the future, these measurement devices could be interchangeable in usage.

Condition or Disease Intervention/Treatment Phase
  • Other: retrospective analyze

Detailed Description

Keratoconus is a degenerative pathology of the cornea, which tends to progress. It comes along with central and paracentral thinning of the cornea as well as with an apical protrusion of the cornea. Keratoconus leads to vision loss. This pathology is diagnosed by using CE certified OCT technology in order to map the topography of the cornea. This process constitutes a really important step in the line of management of the keratoconus. MS39 and Pentacam are used for detection. Retrospectively, data will be investigated, in order to see if these measurement devices deliver comparable results. In the future, these measurement devices could be interchangeable in usage.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Keratoconus Detection Using MS39 and Pentacam - a Retrospective Study
Anticipated Study Start Date :
Nov 3, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Outcome Measures

Primary Outcome Measures

  1. topography of the cornea [12 months]

    measurement of the topography of the cornea with MS39 and Pentacam

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:

  • age older than 14 years

  • patients who show up at Keratokonus consultation hours

Exclusion Criteria:

  • age younger than 14 years

  • age older than 100 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria Linz Oberösterreich Austria 4020

Sponsors and Collaborators

  • Johannes Kepler University of Linz

Investigators

  • Principal Investigator: Matthias Bolz, MD, JKU Linz

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johannes Kepler University of Linz
ClinicalTrials.gov Identifier:
NCT05604443
Other Study ID Numbers:
  • KUK-Ophthalmology-007
First Posted:
Nov 3, 2022
Last Update Posted:
Nov 3, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Johannes Kepler University of Linz
Keratoconus
Pentacam
MS39
Additional relevant MeSH terms:
Keratoconus

Study Results

No Results Posted as of Nov 3, 2022